BioMed Research International / 2020 / Article / Tab 2

Research Article

Tuberculosis Chemotherapy Outcome in the Littoral Region of Cameroon: A Meta-analysis of Treatment Success Rate between 2014 and 2016

Table 2

Correlation between the anti-TB therapy success and rate coverage of CTX and ARV in HIV-positive patients from 2014 to 2016 in the Littoral Region of Cameroon.

Nature of the correlation95% CI value

Treatment success and CTX coverage rates
 Year 201414-0.044-0.562 to 0.4980.883
 Year 2015110.7790.337 to 0.9400.003
 Year 2016130.7580.355 to 0.9230.001
Treatment success and ARV coverage rates
 Year 201414-0.254-0.692 to 0.3190.388
 Year 2015110.240-0.421 to 0.7340.489
 Year 2016130.8060.458 to 0.9400.0004

TB: tuberculosis; CTX: cotrimoxazole; ARV: antiretroviral; HIV: human immunodeficiency virus; : frequency; : Spearman correlation coefficient; 95% CI: confidence interval at 95%; Spearman correlation test and significance was set at value less than 0.05 ().

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.